(Adds detail, Wesfarmers comment)
July 12 (Reuters) - Australian Pharmaceutical Industries (API) on Monday said it has received an unsolicited, non-binding buyout proposal from retail conglomerate Wesfarmers (WES) that values the pharmacy chain operator at A$679.9 mln ($508.9 mln).
Under the offer, shareholders of the pharmaceutical firm would get A$1.38 apiece, a premium of 20.5% to API's last close of A$1.145 on Friday.
The deal would give Wesfarmers access to API's network of retail stores, skincare clinics, and a distribution network of pharmaceutical and healthcare products, marking Wesfarmers' entry into the country's health sector.
"If the proposal is successful, API would form the basis of a new healthcare division of Wesfarmers and a base from which to invest and develop capabilities in the health and wellbeing sector," Wesfarmers said in a separate exchange filing.
API's major shareholder Washington H Soul Pattinson Co (SOL) , which owns 19.3% in the pharmaceutical firm, has indicated its support for the proposal and agreed to vote in favour of it, the retail conglomerate added.
Earlier, API said in a separate filing that it would stop manufacturing personal care and over-the-counter products in New Zealand in a move to simplify its business, and flagged a hit to its earnings for the full-year ending Aug. 31.
($1 = 1.3360 Australian dollars)
News: SOL UPDATE 1-Australian Pharmaceutical Industries gets $509 mln buyout proposal from...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$42.16 |
Change
-0.360(0.85%) |
Mkt cap ! $15.50B | |||
| Open | High | Low | Value | Volume |
| $42.52 | $42.69 | $42.06 | $18.75M | 442.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1239 | $42.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $42.41 | 1088 | 4 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| SOL (ASX) Chart |